AbbVie Inc. Quarterly Long-term Debt and Lease Obligation in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
AbbVie Inc. quarterly Long-term Debt and Lease Obligation history and growth rate from Q4 2012 to Q2 2024.
  • AbbVie Inc. Long-term Debt and Lease Obligation for the quarter ending June 30, 2024 was $58B, a 4.01% increase year-over-year.
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $58B +$2.24B +4.01% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $63.8B +$4.51B +7.61% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $52.2B -$6.94B -11.7% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $55.6B -$4.77B -7.89% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $55.8B -$5.19B -8.51% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $59.3B -$4.23B -6.66% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $59.1B -$5.05B -7.87% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $60.4B -$13.7B -18.4% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $61B -$13.2B -17.8% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $63.5B -$10.7B -14.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $64.2B -$13.4B -17.2% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $74B -$8.23B -10% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $74.2B -$7.82B -9.53% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $74.2B +$10.9B +17.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $77.6B +$14.6B +23.2% Dec 31, 2020 10-K 2022-02-18
Q3 2020 $82.3B +$49.2B +148% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $82.1B +$50.4B +160% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $63.3B +$28.2B +80.5% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $63B +$28B +79.9% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $33.1B -$3.36B -9.21% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $31.6B +$1.04B +3.4% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $35.1B +$4.16B +13.5% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $35B +$4.05B +13.1% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $36.5B +$2.51B +7.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $30.6B -$3.24B -9.58% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $30.9B -$5.62B -15.4% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $31B -$5.49B -15.1% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $34B -$3.31B -8.88% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $33.8B -$3.51B -9.41% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $36.5B +$7.04B +23.9% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $36.4B +$7.2B +24.6% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $37.3B +$5.93B +18.9% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $37.3B +$10.2B +37.7% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $29.5B +$18.8B +176% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $29.2B +$18.7B +177% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $31.4B +$16.9B +117% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $27.1B +$12.6B +87.4% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $10.7B -$3.7B -25.7% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $10.5B -$3.75B -26.3% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $14.5B +$94M +0.65% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $14.5B +$144M +1.01% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $14.4B -$215M -1.47% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $14.3B -$338M -2.31% Dec 31, 2013 10-K 2015-02-20
Q3 2013 $14.4B Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $14.3B Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $14.6B Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $14.6B Dec 31, 2012 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.